The integration of artificial intelligence (AI) into bioprinting workflows and the application of bioprinting for disease modeling and drug screening represent two transformative frontiers in biomedical research. This special issue, titled "AI-Driven Bioprinting Workflows or Bioprinting for Disease Modeling and Drug Screening," delves into the synergistic potential of AI to optimize bioprinting processes, enhance precision, and accelerate the development of functional tissues. Simultaneously, it explores the use of bioprinted constructs to create advanced disease models and high-throughput drug screening platforms, offering unprecedented insights into human physiology and therapeutic discovery. By bridging AI, bioprinting, and biomedical applications, this issue aims to highlight innovative methodologies, interdisciplinary collaborations, and cutting-edge advancements that are shaping the future of regenerative medicine and personalized healthcare.

Scope and Topics:

This special issue invites contributions on:

• AI-driven optimization of bioink formulations and printing parameters.
• Machine learning for predictive modeling of tissue behavior and functionality.
• Bioprinted organ-on-a-chip and tissue models for studying diseases (e.g., cancer, cardiovascular, neurodegenerative).
• High-throughput bioprinting platforms for drug screening and toxicity testing.
• Ethical, regulatory, and commercialization challenges in AI-augmented bioprinting.
• Case studies on clinical translation and industrial scalability of bioprinting technologies.

Submission Guidelines:

Manuscripts should be prepared in accordance with the journal's guidelines, which can be found on the IJB website.

All submissions will undergo a rigorous peer-review process to ensure the publication of high-quality research.

Article Processing Charge (APC):

Please note that an APC of USD 3,000 is applicable for accepted articles.

Contact Information:

For inquiries, please contact the editorial office at:

Email: ijb.office@accscience.sg